Novavax (NASDAQ:NVAX) Coverage Initiated at Citigroup
Analysts at Citigroup initiated coverage on shares of Novavax (NASDAQ:NVAX – Get Free Report) in a note issued to investors on Tuesday, Marketbeat.com reports. The brokerage set a “sell” rating and a $6.00 price target on the biopharmaceutical company’s stock. Citigroup’s price objective would indicate a potential downside of 4.76% from the stock’s previous close. […]
Analysts at Citigroup initiated coverage on shares of Novavax (NASDAQ:NVAX – Get Free Report) in a note issued to investors on Tuesday, Marketbeat.com reports. The brokerage set a “sell” rating and a $6.00 price target on the biopharmaceutical company’s stock. Citigroup’s price objective would indicate a potential downside of 4.76% from the stock’s previous close. […]
